GlassScriptPhysician profile
Isabel B Estes
NPI 1548957228
$1,379.13
in general payments reported to CMS, 2019-2025
14 companies · $65.03 in 2025
The $65.03 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $822 · 2024: $492 · 2025: $65.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.54 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $227.32 | 2023-2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $184.20 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $170.26 | 2023-2025 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $96.87 | 2023-2024 | Aristada, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $81.14 | 2023 | Trintellix |
| Tempus Ai, INC | $66.75 | 2024 | |
| Axsome Therapeutics, INC. | $57.65 | 2023-2024 | Auvelity |
| Lundbeck LLC | $40.02 | 2023-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $36.10 | 2024 | Spravato |
| Teva Pharmaceuticals USA, INC. | $22.89 | 2024 | Austedo Xr |
| Corium, LLC | $22.34 | 2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $21.67 | 2024 | Qelbree |
| Collegium Pharmaceutical, INC. | $19.38 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.